Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Ursodeoxycholic acid254 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A38569 | 10907390 | Mayo Clin Proc | Nonalcoholic steatohepatitis. | 2000 | Details |
| A38961 | 9436007 | Gastroenterologist | Nonalcoholic fatty liver (NASH syndrome). | 1997 | Details |
| A39083 | 9005748 | Ann Intern Med | Nonalcoholic steatohepatitis. | 1997 | Details |
| A39214 | 8675165 | Hepatology | Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. | 1996 | Details |
| A39937 | 1994418 | Radiology | Percutaneous rotational contact biliary lithotripsy: initial clinical results with the Kensey Nash lithotrite. | 1991 | Details |
| A42542 | 34193189 | Nutr Metab (Lond) | Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF/MS. | 2021 | Details |
| A43221 | 32258950 | Hepatol Commun | Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas. | 2020 | Details |
| A44689 | 27734248 | Dig Dis Sci | FXR Agonists: From Bench to Bedside, a Guide for Clinicians. | 2016 | Details |
| A44819 | 27184632 | Saudi J Gastroenterol | Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016? | 2016 | Details |
| A45216 | 25635125 | J Lipid Res | The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination. | 2015 | Details |
| A45550 | 23970447 | Hum Exp Toxicol | Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice. | 2013 | Details |
| A45897 | 22154323 | Metabolism | Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | 2011 | Details |
| A46015 | 21538633 | NMR Biomed | Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. | 2011 | Details |
| A46093 | 21145815 | J Hepatol | UDCA for NASH: end of the story? | 2010 | Details |
| A46144 | 20731092 | Voen Med Zh | [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. | 2010 | Details |
| A46263 | 19938288 | Eksp Klin Gastroenterol | [Drug (statine)-induced hepatitis]. | 2009 | Details |
| A46410 | 21180527 | Therap Adv Gastroenterol | Treatment options for nonalcoholic Fatty liver disease. | 2008 | Details |
| A46492 | 18277910 | J Clin Gastroenterol | Therapy for nonalcoholic fatty liver disease. | 2008 | Details |
| A46597 | 17376209 | Clin Exp Dermatol | Psoriasis treated with ursodeoxycholic acid: three case reports. | 2007 | Details |
| A46610 | 17304406 | Z Gastroenterol | [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. | 2007 | Details |
| A46650 | 16901765 | Clin Gastroenterol Hepatol | A lean man with nonalcoholic fatty liver disease. | 2006 | Details |
| A46691 | 16493965 | Rev Med Suisse | [Hepatology]. | 2006 | Details |
| A46718 | 16245220 | Turk J Gastroenterol | Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. | 2005 | Details |
| A46793 | 15505596 | Ann Hepatol | Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial. | 2005 | Details |
| A46842 | 12792701 | Braz J Med Biol Res | A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. | 2003 | Details |
| A46860 | 12408779 | Curr Treat Options Gastroenterol | Therapeutic Options in Nonalcoholic Fatty Liver Disease. | 2002 | Details |
| A46880 | 11825540 | Curr Gastroenterol Rep | Use of ursodeoxycholic acid in patients with liver disease. | 2002 | Details |
| A46890 | 11296699 | Semin Liver Dis | Treatment of nonalcoholic fatty liver: present and emerging therapies. | 2001 | Details |
| A47097 | 26025474 | Biochimie | Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice. | 2015 | Details |
| A47114 | 25717264 | World J Gastroenterol | Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation. | 2015 | Details |
| A47189 | 23707365 | J Hepatol | ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. | 2013 | Details |
| A47685 | 33708350 | World J Hepatol | Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs. | 2021 | Details |
| A48042 | 25866507 | Gastroenterol Res Pract | Treatment of nonalcoholic steatohepatitis in adults: present and future. | 2015 | Details |
| A48120 | 22556147 | Am J Physiol Gastrointest Liver Physiol | Reducing endoplasmic reticulum stress does not improve steatohepatitis in mice fed a methionine- and choline-deficient diet. | 2012 | Details |
| A48354 | 15570868 | Nihon Shokakibyo Gakkai Zasshi | [Treatment of nonalcoholic steatohepatitis (NASH)]. | 2004 | Details |
| A48367 | 14999677 | Hepatology | Negative trials in nonalcoholic steatohepatitis: why they happen and what they teach us. | 2004 | Details |
| A48373 | 14586875 | Liver Transpl | Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? | 2003 | Details |
| A48401 | 12452368 | Dig Dis Sci | Effect of ursodeoxycholic acid on hepatic steatosis in rats. | 2002 | Details |
| A48478 | 7769192 | J Clin Gastroenterol | Two cases from the spectrum of nonalcoholic steatohepatitis. | 1995 | Details |
| A48660 | 32064266 | Front Med (Lausanne) | Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. | 2020 | Details |
| A48975 | 22543705 | Acta Pharmacol Sin | Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. | 2012 | Details |
| A49145 | 16289367 | Med Hypotheses | Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. | 2005 | Details |
| A49152 | 16185298 | Pathol Int | Post-liver transplantation de novo hepatitis with overlap features. | 2005 | Details |
| A49754 | 35646540 | Acta Pharm Sin B | Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | 2021 | Details |
| A49856 | 35617696 | Expert Rev Gastroenterol Hepatol | Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: A systematic review and meta-analysis. | 2022 | Details |
| A49859 | 35616321 | Clin Transl Gastroenterol | Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational study. | 2022 | Details |
| A50043 | 35548355 | Front Pharmacol | Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats. | 2022 | Details |
| A50262 | 35450649 | Carbohydr Polym | Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1. | 2022 | Details |
| A50494 | 35365570 | Gut | NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. | 2022 | Details |
| A50529 | 35352691 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: opinions, population served, and management from a sample of French hepato(gastroentero)logists (PERSEPT study). | 2022 | Details |
| A51771 | 34236076 | Clin Sci (Lond) | Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress. | 2021 | Details |
| A51988 | 32587408 | Sci Rep | Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy. | 2020 | Details |
| A52193 | 30246717 | Chin Med J (Engl) | Role of X-Box Binding Protein-1 in Fructose-Induced De Novo Lipogenesis in HepG2 Cells. | 2018 | Details |
| A52475 | 26579439 | Acta Pharm Sin B | Bile acid nuclear receptor FXR and digestive system diseases. | 2015 | Details |